## ALL: Allstate Corporation (The) - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.23 indicates fundamental undervaluation. Quality metrics strong (ROE 34%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-3.7% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($197.44)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Allstate Corp Reports November 2025 Catastrophe Losses**
- Source: TradingView â€” Track All Markets | 20251218T180924 | Somewhat-Bearish | Relevance: 100%
- Allstate Corp (ALL) announced estimated catastrophe losses of $46 million for November 2025, which amounted to $36 million after-tax. The total catastrophe losses for October-November 2025 reached $129 million, or $101 million after-tax. The company also reported slight increases in auto and homeowners policies from October to November 2025, while commercial lines policies remained stable.

**2. William Blair downgrades Kemper stock rating amid auto insurance sector concerns**
- Source: Investing.com | 20251218T120847 | Somewhat-Bearish | Relevance: 73%
- William Blair downgraded Kemper Corp (NYSE:KMPR) from Outperform to Market Perform due to deteriorating auto insurance fundamentals. This is part of a broader reassessment of the auto insurance sector, with the firm expecting rising loss ratios and lower earnings for Kemper in late 2026. Despite a 34% decline in shares over the past six months, Kemper has maintained dividend payments for 36 consecutive years.

**3. William Blair downgrades Progressive stock rating to Market Perform**
- Source: Investing.com | 20251218T122541 | Somewhat-Bearish | Relevance: 63%
- William Blair downgraded Progressive Corp. (NYSE:PGR) from Outperform to Market Perform, citing deteriorating auto insurance sector fundamentals. This broader reassessment also led to downgrades for Allstate and Kemper. Despite the near-term challenges, William Blair maintains a positive long-term outlook for Progressive, expecting it to be an "industry winner."

**4. Wells Fargo lowers Progressive stock price target to $242 on growth concerns**
- Source: Investing.com | 20251219T120842 | Somewhat-Bearish | Relevance: 63%
- Wells Fargo has reduced its price target for Progressive Corp. (NYSE:PGR) to $242.00 from $247.00, citing concerns about a tightening growth environment despite attractive valuation metrics. The firm noted that expectations for higher combined ratios and lower-than-anticipated share repurchases contributed to a less constructive outlook for the stock, particularly looking towards 2026. This adjustment comes amidst mixed recent performance from Progressive and similar re-evaluations from other analysts.

**5. Wells Fargo lowers Progressive stock price target to $242 on growth concerns**
- Source: Investing.com | 20251219T120821 | Somewhat-Bearish | Relevance: 63%
- Wells Fargo has reduced its price target for Progressive Corp. (NYSE:PGR) to $242.00 from $247.00, citing a "tougher" growth environment and lower-than-expected share repurchases. Despite this, InvestingPro data suggests the stock may be undervalued. Other analysts have also adjusted their ratings, with concerns about slowing policy growth contrasting with better-than-expected November operating earnings.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | William Blair | $0 | $0 | 0% |
| 2025-12-16 | Mizuho | $254 | $0 | 0% |
| 2025-12-16 | Morgan Stanley | $215 | $245 | -12% |
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | William Blair | down | Market Perform |
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-16 | Morgan Stanley | down | Equal-Weight |
| 2025-11-26 | Roth Capital | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.16M) |
| Sells | 13 ($14.04M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.7% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $14M sold (13 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.23 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($14.0M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $54.0B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.23 |
| Forward P/E | 8.5 |
| Current P/E | 7.1 |
| YoY Growth | -16.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 2.0% to -1.7% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.7pp (needs >4.0% for momentum thesis). Underperforming sector by 3.6pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 47. Elevated volume (1.8x 20MA), institutional activity likely. OFD pattern: +DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.68% (CS: 33) | Neutral |
| RSI_14 | 47.1 | Neutral |
| MACD Histogram | -0.33 | Bearish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 1.008x | Above |
| vs SMA200 | 1.014x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $204.96
- **Stop Loss:** $197.44 (3.7% risk)
- **Target:** $220.00 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 119
- **Position Value:** $24,390.24
- **Portfolio %:** 24.39%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*